Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab

The recent introduction of direct oral anticoagulants, including rivaroxaban, dabigatran, apixaban, and edoxaban, for the acute treatment and secondary prevention of venous thromboembolism and in atrial fibrillation has been shown to provide greater clinical benefit than oral vitamin K antagonists....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SAGE Open Med Case Rep
Hauptverfasser: Riario Sforza, Gian Galeazzo, Gentile, Francesco, Stock, Fabio, Caggiano, Francesco, Chiocca, Enrica, Incorvaia, Cristoforo
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2018
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768245/
https://ncbi.nlm.nih.gov/pubmed/29348918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17753336
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge